Farnesyltransferase inhibitors as radiation sensitizers

Seminars in Radiation Oncology

Volumn 12, Issue 3 SUPPL. 2, 2002, Pages 27-32

  McKenna, W Gillies ^a   Muschel, Ruth J ^a   Gupta, Anjali K ^a   Hahn, Stephen M ^a   Bernhard, Eric J ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 2 [[2 [[2 [(2 AMINO 3 MERCAPTOPROPYL)AMINO] 3 METHYLPENTYL]OXY] 1 OXO 3 PHENYLPROPYL]AMINO] 4 (METHYLSULFONYL)BUTANOIC ACID ISOPROPYL ESTER; AMINO ACID; ANTISENSE OLIGONUCLEOTIDE; DIMETHYLALLYLTRANSFERASE; EPIDERMAL GROWTH FACTOR RECEPTOR; GERANYLTRANSFERASE; GGTI 297; GGTI 298; L 778123; N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE; N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE METHYL ESTER; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RAS PROTEIN; TIPIFARNIB; TRANSFERASE INHIBITOR; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

CANCER INHIBITION; CANCER RADIOTHERAPY; CLINICAL TRIAL; ESOPHAGITIS; FATIGUE; GASTROINTESTINAL SYMPTOM; HEAD AND NECK CANCER; HUMAN; LUNG NON SMALL CELL CANCER; MUCOSA INFLAMMATION; NEUTROPENIA; NONHUMAN; ONCOGENE RAS; PANCREAS CANCER; PRIORITY JOURNAL; RADIOSENSITIVITY; RADIOSENSITIZATION; REVIEW;

EID: 0036638229     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1053/srao.2002.34866     Document Type: Review

References (21)

1. Synergistic effect of the v-myc oncogene with H-ras on radioresistance
2. The Role of the H-ras oncogene in radiation resistance and metastasis
3. Radiosensitization of human tumor cell lines induced by the adenovirus-mediated expression of an anti-Ras single-chain antibody fragment
4. The farnesyllransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblasts
5. Inhibiting Ras prenylation increases the radiosensitivity of human tumor cell lines with activating mutations of ras oncogenes
6. Prenyltransferase inhibitors as radiosensitizers
7. Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRAS
8. Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines
9. The Ras radiation resistance pathway
10. C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability
11. The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities
12. Head and neck cancer as a clinical model for molecular targeting of therapy: Combining EGFR blockade with radiation
13. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody
14. Radioresistance induced by the high molecular forms of the basic fibroblast growth factor is associated with an increased G2 delay and a hyperphosphorylation of p34CDC2 in HeLa cells
15. Regulation of radiation-induced apoptosis in oncogene-transfected fibroblasts: Influence of H-ras on the G2 delay
16. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy
17. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: Analysis of 101 published survival curves
18. A phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer
19. Prenylation of RhoB is required for its cell transforming function but not its ability to activate serum response element-dependent transcription
20. Non-Ras targets of farnesyltransferase inhibitors: Focus on Rho
21. Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity